Works matching DE "TRASTUZUMAB"
Results: 2901
Immune-enrichment Predicts Response to Trastuzumab.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 7, p. III
- Publication type:
- Article
Cardiovascular Toxicity of Newer Chemotherapeutic Agents: The Heart of the Matter.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 493
- By:
- Publication type:
- Article
Cardiovascular Toxicity of Biologic Agents for Cancer Therapy.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 482
- By:
- Publication type:
- Article
HER2-Positive Breast Cancer: The Story Goes On.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 4, p. 290
- By:
- Publication type:
- Article
HER2-Directed Therapy for Metastatic Breast Cancer.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 3, p. 166
- By:
- Publication type:
- Article
Subcutaneous Trastuzumab (Herceptin) Injection Shows Promise.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 9, p. 873
- Publication type:
- Article
What Is the Current Standard of Care for Anti-HER2 Neoadjuvant Therapy in Breast Cancer?
- Published in:
- Oncology (08909091), 2012, v. 26, n. 1, p. 20
- By:
- Publication type:
- Article
HER2-Targeted Therapies: How Far We've Come--and Where We're Headed.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 5, p. 425
- By:
- Publication type:
- Article
Targeting Alternative Pathways in HER2-Positive Breast Cancer.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 415
- By:
- Publication type:
- Article
HER2-Positive Breast Cancer: Beyond Trastuzumab.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 410
- By:
- Publication type:
- Article
Trastuzumab: Mechanisms of Resistance and Therapeutic Opportunities.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1250
- By:
- Publication type:
- Article
Trastuzumab Resistance: Bringing Tailored Therapy to the Clinic.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1259
- By:
- Publication type:
- Article
Breast Cancer Study Establishes New Model for Global Clinical Trials.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 3, p. 257
- Publication type:
- Article
Study Supports Activity of Gemcitabine in Treatment of Early-Stage Breast Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 11, p. 1285
- Publication type:
- Article
What Progress Have We Made in Managing Inflammatory Breast Cancer?
- Published in:
- Oncology (08909091), 2007, v. 21, n. 6, p. 673
- By:
- Publication type:
- Article
Landmark Lapatinib Data Published.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 1, p. 108
- Publication type:
- Article
HER2-Positive Breast Cancer: Remaining Challenges.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1775
- By:
- Publication type:
- Article
Trastuzumab: Further Considerations.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1771
- By:
- Publication type:
- Article
Trastuzumab and Beyond: New Possibilities for the Treatment of HER2-Positive Breast Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1763
- By:
- Publication type:
- Article
Boosting Killer Cells Might Improve Breast Cancer Drug.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 9, p. 1114
- Publication type:
- Article
Serum HER2/neu Change Predicts Clinical Outcome to Trastuzumab-Based Therapy.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 9, p. 1094
- Publication type:
- Article
HERA Trial Follow-up Continues to Demonstrate Significant Patient Benefits From Herceptin.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 9, p. 1092
- Publication type:
- Article
A Woman With Primary Breast Cancer and a Solitary Sternal Metastasis.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 9, p. 1068
- By:
- Publication type:
- Article
Understanding Breast Cancer Management and Treatment.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 9, p. 975
- Publication type:
- Article
Fourth Phase III Study Shows Trastuzumab/Chemotherapy Improved Disease-Free Survival in Breast Cancer Patients.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 11, p. 1
- Publication type:
- Article
Oncology NEWS INTERNATIONAL.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 7, p. 862
- Publication type:
- Article
Trastuzumab Plus Chemotherapy Improves Survival in Early-Stage HER2-Positive Breast Cancer Patients.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 7, p. 851
- Publication type:
- Article
HER2 testing: The patent "genee" is out of the bottle.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis.
- Published in:
- CMAJ: Canadian Medical Association Journal Supplement, 2007, v. 176, n. 10, p. 1429, doi. 10.1503/cmaj.061011
- By:
- Publication type:
- Article
Coamplification with Colocalization of the Human Epidermal Growth Factor Receptor 2 and Centromeric-17 Signals on Fluorescence In Situ Hybridization in Invasive Breast Carcinoma: An Exceedingly Rare Finding.
- Published in:
- Journal of Postgraduate Medicine, 2016, v. 62, n. 3, p. 210, doi. 10.4103/0022-3859.186394
- By:
- Publication type:
- Article
A case study of trastuzumab treatment for metastatic breast cancer in pregnancy: fetal risks and management of cerebral metastases.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2011, v. 51, n. 4, p. 372, doi. 10.1111/j.1479-828X.2011.01314.x
- By:
- Publication type:
- Article
Radiolabelled <sup>177</sup>Lu‐Bispidine‐Trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancers.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 14, p. 1, doi. 10.1002/chem.202303805
- By:
- Publication type:
- Article
Chemoselective Methionine Labelling of Recombinant Trastuzumab Shows High In Vitro and In Vivo Tumour Targeting.
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 11, p. 1, doi. 10.1002/chem.202202491
- By:
- Publication type:
- Article
Two-Step Targeted Hybrid Nanoconstructs Increase Brain Penetration and Efficacy of the Therapeutic Antibody Trastuzumab against Brain Metastasis of HER2-Positive Breast Cancer.
- Published in:
- Advanced Functional Materials, 2018, v. 28, n. 9, p. 1, doi. 10.1002/adfm.201705668
- By:
- Publication type:
- Article
Exploring the dynamics and interaction of a full ErbB2 receptor and Trastuzumab-Fab antibody in a lipid bilayer model using Martini coarse-grained force field.
- Published in:
- Journal of Computer-Aided Molecular Design, 2014, v. 28, n. 11, p. 1093, doi. 10.1007/s10822-014-9787-2
- By:
- Publication type:
- Article
Trastuzumab and breast cancer: developments and current status.
- Published in:
- International Journal of Clinical Oncology, 2006, v. 11, n. 3, p. 199, doi. 10.1007/s10147-006-0575-4
- By:
- Publication type:
- Article
Antibodies as molecular target-based therapy: trastuzumab.
- Published in:
- International Journal of Clinical Oncology, 2003, v. 8, n. 4, p. 224, doi. 10.1007/s10147-003-0334-8
- By:
- Publication type:
- Article
Population pharmacokinetics and exposure–response relationship of trastuzumab and bevacizumab in early-stage breast cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 12, p. 1861, doi. 10.1007/s00228-021-03179-w
- By:
- Publication type:
- Article
Uptake of biosimilar trastuzumab in Denmark compared with other European countries: a comparative study and discussion of factors influencing implementation and uptake of biosimilars.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1495, doi. 10.1007/s00228-021-03155-4
- By:
- Publication type:
- Article
Use of population approach non-linear mixed effects models in the evaluation of biosimilarity of monoclonal antibodies.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 11, p. 1343, doi. 10.1007/s00228-016-2101-6
- By:
- Publication type:
- Article
Off-label use of anti-cancer drugs between clinical practice and research: the Italian experience.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 505, doi. 10.1007/s00228-011-1173-6
- By:
- Publication type:
- Article
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 811, doi. 10.1007/s00228-011-1181-6
- By:
- Publication type:
- Article
Trastuzumab and survival of patients with metastatic breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Trastuzumab (herceptin): a retrospective analysis of the effects of long-term application in a series of patients with breast cancer.
- Published in:
- Archives of Gynecology & Obstetrics, 2014, v. 290, n. 4, p. 733, doi. 10.1007/s00404-014-3261-1
- By:
- Publication type:
- Article
Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients.
- Published in:
- Archives of Gynecology & Obstetrics, 2012, v. 285, n. 2, p. 485, doi. 10.1007/s00404-011-1954-2
- By:
- Publication type:
- Article
Trastuzumab Emtansine-Induced Nodular Regenerative Hyperplasia: Is Dose Reduction Enough as a Preventable Measure?
- Published in:
- Digestive Diseases, 2022, v. 40, n. 6, p. 787, doi. 10.1159/000521933
- By:
- Publication type:
- Article
Trastuzumab Deruxtecan for the Treatment of HER2-low Advanced or Metastatic Breast Cancer.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 1, p. 36, doi. 10.17925/ohr.2024.20.1.8
- By:
- Publication type:
- Article
Tailoring the Treatment of Early-stage HER2-positive Breast Cancer: One Size Does Not Fit All.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 11, doi. 10.17925/OHR.2023.19.1.11
- By:
- Publication type:
- Article
Trastuzumab Deruxtecan for the Treatment of HER2-positive Breast Cancer.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 6, doi. 10.17925/OHR.2023.19.1.6
- By:
- Publication type:
- Article
HER2-positive breast cancer - Available anti-HER2 therapies and new agents under investigation.
- Published in:
- Journal of Pre-Clinical & Clinical Research, 2020, v. 14, n. 2, p. 44, doi. 10.26444/jpccr/122068
- By:
- Publication type:
- Article